{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:01:06Z","timestamp":1761490866607},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Public Health"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1007\/bf03403742","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T20:20:40Z","timestamp":1568319640000},"page":"57-61","source":"Crossref","is-referenced-by-count":15,"title":["Epidemiology of Invasive Pneumococcal Disease in BC during the Introduction of Conjugated Pneumococcal Vaccine"],"prefix":"10.17269","volume":"99","author":[{"given":"Meghan","family":"Winters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawziah","family":"Marra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Buxton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith L.","family":"Isaac-Renton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Tyrrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marguerite","family":"Lovgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephane","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,1]]},"reference":[{"key":"BF03403742_CR1","volume-title":"World Health Organization","author":"WHO. Overcoming antimicrobial resistance.","year":"2000","unstructured":"WHO. Overcoming antimicrobial resistance. World Health Organization, 2000. Available online at: \n                    https:\/\/doi.org\/www.who.int\n                    \n                  \/infectious-disease-report\/2000\/index.html (Accessed October 20, 2005)."},{"key":"BF03403742_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0924-8579(02)00394-1","volume":"21","author":"M Cizman","year":"2003","unstructured":"Cizman M. The use and resistance to antibiotics in the community. Int J Antimicrob Agents 2003;21:297\u2013307.","journal-title":"Int J Antimicrob Agents"},{"key":"BF03403742_CR3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/bmj.317.7159.654","volume":"317","author":"H Goossens","year":"1998","unstructured":"Goossens H, Sprenger M. Community acquired infections and bacterial resistance. BMJ 1998;317:654\u201357.","journal-title":"BMJ"},{"key":"BF03403742_CR4","first-page":"885","volume":"167","author":"J Conly","year":"2002","unstructured":"Conly J. Antimicrobial resistance in Canada. CMAJ 2002;167:885\u201391.","journal-title":"CMAJ"},{"key":"BF03403742_CR5","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1128\/AAC.48.9.3305-3311.2004","volume":"48","author":"J Powis","year":"2004","unstructured":"Powis J, McGeer A, Green K, Vanderkooi O, Weiss K, Zhanel G, et al. In vitro antimicrobial susceptibilities of streptococcus pneumoniae clinical isolates obtained in Canada in 2002. Antimicrob Agents Chemother 2004;48:3305\u201311.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF03403742_CR6","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","volume":"343","author":"CG Whitney","year":"2000","unstructured":"Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, et al. Increasing prevalence of multidrug-resistant Streptococcus pneu-moniae in the United States. N Engl J Med 2000;343:1917\u201324.","journal-title":"N Engl J Med"},{"key":"BF03403742_CR7","volume-title":"CCDR","author":"National Advisory Committee on Immunization.","year":"2002","unstructured":"National Advisory Committee on Immunization. Statement on recommended use of pneumococcal conjugate vaccine. CCDR 2002;28 (ACS-2)."},{"key":"BF03403742_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJM199907223410403","volume":"341","author":"DK Chen","year":"1999","unstructured":"Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneu-moniae to fluoroquinolones in Canada. N Engl J Med 1999;341:233\u201339.","journal-title":"N Engl J Med"},{"key":"BF03403742_CR9","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1128\/AAC.47.6.1867-1874.2003","volume":"47","author":"GG Zhanel","year":"2003","unstructured":"Zhanel GG, Palatnick L, Nichol KA, Bellyou T, Low DE, Hoban DJ. Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: Results of the Canadian Respiratory Organism Susceptibility study, 1997 to 2002. AAC 2003;47:1867\u201374.","journal-title":"AAC"},{"key":"BF03403742_CR10","first-page":"157","volume":"32","author":"S Paulus","year":"2006","unstructured":"Paulus S, David ST, Tang W, Winters M, Buxton J, Henry B, et al. Incidence of invasive pneumococcal disease after the introduction of the universal immunization programme in B.C. (2002\u20132005). CCDR 2006;32:157\u201361.","journal-title":"CCDR"},{"key":"BF03403742_CR11","volume-title":"National Committee for Clinical Laboratory Standards","author":"National Committee for Clinical Laboratory Standards.","year":"2004","unstructured":"National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Fourteenth informational supplement. Document standard M100-14. In: National Committee for Clinical Laboratory Standards, Wayne, PA, 2004."},{"key":"BF03403742_CR12","volume-title":"Population Extrapolation for Organizational Planning with Less Error (P.E.O.P.L.E.)","author":"BC STATS, BC Ministry of LabourCitizens ServicesHealth Data Warehouse.","year":"2005","unstructured":"BC STATS, BC Ministry of Labour and Citizens Services and Health Data Warehouse. Population Extrapolation for Organizational Planning with Less Error (P.E.O.P.L.E.), 2005."},{"key":"BF03403742_CR13","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa022823","volume":"348","author":"CG Whitney","year":"2003","unstructured":"Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737\u201346.","journal-title":"N Engl J Med"},{"key":"BF03403742_CR14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0140-6736(05)71043-6","volume":"365","author":"D Stephens","year":"2005","unstructured":"Stephens D, Zughaier S, Whitney C, Baughman WS, Barker L, Gay K, et al. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: Population-based assessment. Lancet 2005;365:855\u201363.","journal-title":"Lancet"},{"key":"BF03403742_CR15","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1056\/NEJMoa051642","volume":"354","author":"MH Kyaw","year":"2006","unstructured":"Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006;354:1455\u201363.","journal-title":"N Engl J Med"},{"key":"BF03403742_CR16","volume-title":"National Immunization Survey","author":"Centre for Disease Control.","year":"2005","unstructured":"Centre for Disease Control. National Immunization Survey, 2005 data. Available online at: \n                    https:\/\/doi.org\/www2a.cdc.gov\n                    \n                  \/nip\/coverage\/nis\/nis_iap.asp?fmt=v&rpt=tab09_24mo_iap&qtr=Q1\/2005-Q4\/2005 (Accessed March 15, 2007)."},{"key":"BF03403742_CR17","unstructured":"Centre for Disease Control. Early Release of Selected Estimates Based on Data From the January-March 2006 National Health Interview Survey. Available online at: \n                    https:\/\/doi.org\/www.cdc.gov\n                    \n                  \/nchs\/data\/nhis\/earlyrelease\/200609_05.pdf (Accessed March 15, 2007)."},{"key":"BF03403742_CR18","volume-title":"Performance measure 32: Two-year olds with up-to-date immunizations. 2005 cycle","author":"BC Centre for Disease Control.","year":"2006","unstructured":"BC Centre for Disease Control. Performance measure 32: Two-year olds with up-to-date immunizations. 2005 cycle. Vancouver, BC, 2006."},{"key":"BF03403742_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJM199907223410403","volume":"341","author":"DK Chen","year":"1999","unstructured":"Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneu-moniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 1999;341:233\u201339.","journal-title":"N Engl J Med"},{"key":"BF03403742_CR20","unstructured":"Canadian Bacterial Surveillance Network. Trends in Antimicrobial Resistance in Streptococcus pneumoniae - Canada. Available online at: \n                    https:\/\/doi.org\/microbiology.mtsinai.on.ca\n                    \n                  \/data\/sp\/sp_can.shtml (Accessed April 26, 2006)."},{"key":"BF03403742_CR21","unstructured":"Canadian Bacterial Surveillance Network. Trends in Antimicrobial Resistance in Streptococcus pneumoniae - British Columbia. Available online at: \n                    https:\/\/doi.org\/microbiology.mtsinai.on.ca\n                    \n                  \/data\/sp\/sp_bc.shtml (Accessed April 26, 2006)."},{"key":"BF03403742_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1473-3099(05)70083-9","volume":"5","author":"WP Hausdorff","year":"2005","unstructured":"Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococ-cal serotypes. Lancet Infect Dis 2005;5:83\u201393.","journal-title":"Lancet Infect Dis"},{"key":"BF03403742_CR23","volume-title":"Am J Med","author":"TM File Jr.","year":"2004","unstructured":"File TM, Jr. Streptococcus pneumoniae and community-acquired pneumonia: A cause for concern. Am J Med 2004;117(Suppl 3A):39S-50S."},{"key":"BF03403742_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1086\/380126","volume":"38","author":"E Nuermberger","year":"2004","unstructured":"Nuermberger E, Bishai WR. The clinical significance of macrolide-resistant Streptococcus pneu-moniae: It\u2019s all relative. Clin Infect Dis 2004;38:99\u2013103.","journal-title":"Clin Infect Dis"},{"key":"BF03403742_CR25","volume-title":"Clin Infect Dis","author":"IJ Lynch","year":"2002","unstructured":"Lynch IJ, Martinez FJ. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. Clin Infect Dis 2002;34(Suppl 1):S27-S46."},{"key":"BF03403742_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1086\/497594","volume":"42","author":"LR Peterson","year":"2006","unstructured":"Peterson LR. Penicillins for treatment of pneu-mococcal pneumonia: Does in vitro resistance really matter? Clin Infect Dis 2006;42:224\u201333.","journal-title":"Clin Infect Dis"}],"container-title":["Canadian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03403742.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03403742\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03403742.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T16:42:30Z","timestamp":1568392950000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03403742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["BF03403742"],"URL":"https:\/\/doi.org\/10.1007\/bf03403742","relation":{},"ISSN":["0008-4263","1920-7476"],"issn-type":[{"value":"0008-4263","type":"print"},{"value":"1920-7476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}